Source: FARM FUTURES, 12/1/17

The Bayer acquisition of Monsanto continues to move forward, though additional review in Europe is slowing the process. The two companies got good news Friday (Dec. 1) when the Committee on Foreign Investment in the United States completed its review of the deal. CFIUS has concluded there are no unresolved national security concerns with the transaction.This is one more step on the road to completing the acquisition, which both companies had originally hoped to complete in 2017.

For more of this story, click here.